Clinical Trial Update: 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on 99mTc Sestamibi scans in thyroglobulin-positive, scan-negative differentiated thyroid cancer patients; status: terminated with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Thyroid Cancer | Phase 4 | Status: TERMINATED | Results posted: 2022-07-26